CVS expects ’22 growth as pandemic’s grip eases

Sadye Matula

CVS Health and Wall Road share the identical view of the drugstore chain’s advancement prospective as covid-19’s impact on the business begins to relieve. Normal analyst expectations for 2022 earnings of $8.20 for each share suit in CVS Health’s envisioned first forecast for the new year, Chief Fiscal Officer Shawn […]